Our latest issue, No 03 2021, is out – sign up for a subscription today and stay updated on the Nordic life science industry’s latest progress and challenges.
The Nordic life science industry has not only survived, but managed to grow and develop during the pandemic. Read more about how the past 1.5 years have also brought valuable lessons, including the importance of collaboration and how to shorten development pathways in other areas too.
Our profile in this issue, Malin Parkler, CEO, Pfizer Sweden, shares her thoughts on leadership, the future of healthcare and Nordic life sciences, and the importance of staying curious. We have also taken a closer look at US life sciences under President Biden, three Nordic startups share their journeys so far and their advice to aspiring life science entrepreneurs, and much more!
Sign up for a subscription today!